IDiyas

For the Inventor, By the Inventor

Nara, Japan

Masami Eigyo

USPTO Granted Patents = 16

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 216(Granted Patents)


Location History:

  • Kawanishi, JP (1981)
  • Nara, JP (1985 - 1995)
  • Ikoma, JP (1993 - 1997)

Company Filing History:

goldMedal15 out of 1,001 
 
Shionogi Company Limited
 patents
silverMedal1 out of 1 
 
Shionigi & Co., Ltd.
 patent

Years Active: 1981-1997

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5677305 - Oxopyridinylquinoxaline derivative (1997-10-14),
2. 5410058 - Tetrahydropyridine derivatives (1995-04-25),
3. 5362873 - Tetrahydropyridine derivatives (1994-11-08),
4. 5243051 - Tetrahydropyridine derivatives (1993-09-07),
5. 5242915 - Formulation useful for the inhibition of massive release of cerebral (1993-09-07),
6. 5202345 - Carbamoylpyrrolidone derivatives and drugs for senile dementia (1993-04-13),
7. 5149817 - Teirahydropyridine derivatives (1992-09-22),
8. 5120733 - Carbamoylpyrrolidone derivatives and drugs for senile dementia (1992-06-09),
9. 4977167 - Carbamoylpyrolidone derivatives and drugs for senile dementia (1990-12-11),
10. 4940714 - 2-substituted carbonylimidazo[4,5-c]quinolines (1990-07-10),
11. 4923984 - Pyrrolo(1,4)benzodiazepine derivatives (1990-05-08),
12. 4904663 - N-(2-oxpyrrolidin-1-yl-)acetyl)piperazine derivatives and drug for (1990-02-27),
13. 4753951 - Condensed imidazopyridine derivatives useful as psychotropic agents (1988-06-28),
14. 4690930 - Pyrazolo[4,3-c]quinoline-3-one and imidazo[4,3-c]cinnolin-3-one (1987-09-01),
15. 4560684 - 1,4-Benzodiazepine derivatives (1985-12-24),

Title: **Masami Eigyo: Innovator in Neuropharmacology and Tetrahydropyridine Derivatives**

Introduction

Masami Eigyo, an esteemed inventor based in Nara, Japan, has made significant contributions to the field of neuropharmacology. With a remarkable portfolio of 16 patents, his work focuses on developing novel compounds that hold promise for treating various neurological and psychological disorders. His innovative approach has garnered attention within the scientific community and among pharmaceutical companies.

Latest Patents

Among his latest inventions, Eigyo has developed an **Oxopyridinylquinoxaline derivative**, represented by a specific chemical formula. This derivative offers potential therapeutic benefits as an antagonistic agent against both NMDA and AMPA receptors. As such, it may play a crucial role in treating neurological disorders linked to excitatory amino acids interacting with these receptors. Additionally, his work on **Tetrahydropyridine derivatives** has demonstrated high affinity and specificity for sigma receptors, indicating potential applications in managing certain types of psychoses.

Career Highlights

Masami Eigyo has worked with reputable organizations, including Shionogi & Company Limited and Shionogi & Co., Ltd. His career has been marked by a dedication to advancing pharmacological research and developing innovative therapeutic agents. Through his patents, Eigyo continues to influence the landscape of neurological treatment options.

Collaborations

Throughout his career, Eigyo has collaborated with esteemed colleagues such as Akira Matsushita and Hiromu Matsumura, who have contributed to his research endeavors. These collaborations have fostered an environment of innovation and knowledge exchange, leading to significant breakthroughs in the field.

Conclusion

In conclusion, Masami Eigyo is a prominent inventor whose work has the potential to change the treatment landscape for neurological and psychological disorders. His innovative patents and collaborations reflect a commitment to advancing medical science, and his contributions will likely continue to inspire future research and development in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…